Nehemiah Kipyegon
Kenyan Mehemiah Kipyegon has been banned for three years by the Athletics Integrity Unit for doping.
The WADA-accredited laboratory in Lausanne, Switzerland, reported a positive test for Trimetazidine in February from a sample taken from the athlete in Nigeria in February. By April, Kipyegon accepted the suspension and admitted to inadvertently taking the performance-enhancing drug.
Kipyegon holds personal bests of 1:00:34 in the half marathon from Copenhagen in September 2024 and 28:24 over the 10K distance from Montereau, France in October that year. Earlier in 2024 at Nyayo National Stadium in Nairobi, Kenya, he clocked 13:57.30 in the 5000m.
Trimetazidine is a medication primarily used to prevent angina attacks. Angina is chest pain caused by reduced blood flow to the heart. It’s a metabolic agent.
Maryna Bekh-Romanchuk
Two-time World Championships silver medallist in the triple jump, Maryna Oleksandrivna Bekh-Romanchuck, has been provisionally suspended for the presence of Testosterone (T). The Athletics Integrity Unit announced the suspension on Wednesday, May 14.
The long jump and triple jump specialist also competed during the 2024 Paris Olympic Games, finishing in fifth position in the long jump.
The 29-year-old is a 12-time national champion in the long jump and a multi-time Diamond League winner.
Androgens such as T are considered beneficial for athletic performance due to the potent anabolic effects on muscle mass and bone tissue. Testosterone also increases circulating hemoglobin, which enhances oxygen uptake.
